Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
701 Anacapa Street, Santa Barbara, CA, 93101, United States
Market Cap
1.277M
52 Wk Range
$0.25 - $14.28
Previous Close
$0.62
Open
$0.62
Volume
5,422
Day Range
$0.62 - $0.73
Enterprise Value
2.978M
Cash
2.213M
Avg Qtr Burn
-509.7K
Insider Ownership
3.84%
Institutional Own.
7.38%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders | Phase 2 Initiation |